Hyong Kim
CIK 1993255 · View on SEC EDGAR ↗
First SEC filing: Sept. 27, 2023 · Latest: June 15, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 12, 2026 | ALHC | S 10b5-1 | 35,951 | $19.86 | $713,987 | 331,750 Direct | -9.78% | Disposed | -34.0% (price as of 2026-08-21) |
| March 19, 2024 | ALHC | S | 5,576 | $5.05 | $28,159 | 555,530 Direct | -0.99% | Disposed | 159.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 27, 2023 | ALHC | Common Stock | 62,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ALHC
M.D.Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $560,000 | — | $1,800,016 | — | $754,585 | — | $14,420 | $3,129,021 |
| 2024 | $555,693 | — | $1,400,000 | — | $508,334 | — | $14,045 | $2,478,072 |
| 2023 | $140,000 | $20,000 | $2,787,000 | — | $112,277 | — | — | $3,059,277 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.